MediWound (MDWD) Change in Accured Expenses (2013 - 2025)
MediWound (MDWD) recorded quarterly Change in Accured Expenses of -$1.1 million in Q2 2025, down 261.84% quarter-over-quarter from -$304000.0 in Q2 2024, and down 261.84% on a YoY basis from $679674.8 in Q2 2024.
MediWound (MDWD) Change in Accured Expenses (2013 - 2025) Analysis & Trends
MediWound's Change in Accured Expenses history runs 13 years deep, the most recent figure standing at -$1.1 million for Q2 2025.
- In Q2 2025, Change in Accured Expenses fell 261.84% year-over-year to -$1.1 million; the TTM figure through Jun 2025 stood at -$5.3 million (down 89.52% YoY), while the FY2024 annual figure was $1.3 million, down 45.63% from the prior year.
- Change in Accured Expenses was -$1.1 million for Q2 2025 at MediWound, down from -$304000.0 in the prior quarter.
- In the past five years, Change in Accured Expenses ranged from a high of $1.4 million in Q2 2021 to a low of -$2.0 million in Q2 2022.
- Historically, Change in Accured Expenses has averaged -$783000.0 across 5 years, with a median of -$1.1 million in 2025.
- The sharpest annual moves came in 2021 and 2025: Change in Accured Expenses surged 290.6% in 2021, then sank 261.84% in 2025.
- A 5-year view of Change in Accured Expenses shows it stood at $1.4 million in 2021, then tumbled by 243.17% to -$2.0 million in 2022, then gained by 6.64% to -$1.9 million in 2023, then jumped by 83.98% to -$304000.0 in 2024, then tumbled by 261.84% to -$1.1 million in 2025.
- The last three Change in Accured Expenses figures came in at -$1.1 million (Q2 2025), -$304000.0 (Q2 2024), and -$1.9 million (Q2 2023), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change Accured Exp. (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 719,706.53 Bn | 719,706.50 Bn | - | - |
| 2 | Belite Bio | 55,800.00 Bn | 55,800.00 Bn | - | - |
| 3 | Quantum Biopharma | 18,182.30 Bn | 18,182.29 Bn | - | - |
| 4 | Legend Biotech | 3,154.00 Bn | 3,153.71 Bn | 242.10 Mn | - |
| 5 | Akari Therapeutics | 1,844.30 Bn | 1,844.29 Bn | - | 931,000.00 |
| 6 | Evaxion A | 1,567.96 Bn | 1,567.94 Bn | - | - |
| 7 | Psyence Biomedical | 251.43 Bn | 251.42 Bn | - | 644,700.00 |
| 8 | Vertex Pharmaceuticals | 112.56 Bn | 105.31 Bn | 2.59 Bn | 70.50 Mn |
| 9 | Abivax | 94.37 Bn | 94.37 Bn | - | - |
| 10 | MediWound | 3.70 Mn | 3.70 Mn | 278,000.00 | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2025 | -1.10 Mn |
| Jun 30, 2025 | -1.10 Mn |
| Jun 30, 2024 | -304,000.00 |
| Jun 30, 2024 | -304,000.00 |
| Jun 30, 2023 | -1.90 Mn |
| Jun 30, 2023 | -1.90 Mn |
| Jun 30, 2022 | -2.03 Mn |
| Jun 30, 2022 | -2.03 Mn |
| Jun 30, 2021 | 1.42 Mn |
| Jun 30, 2021 | 1.42 Mn |
| Jun 30, 2020 | -745,000.00 |
| Jun 30, 2020 | -745,000.00 |
| Jun 30, 2019 | 3.26 Mn |
| Jun 30, 2019 | 3.26 Mn |
| Jun 30, 2018 | -2.59 Mn |
| Jun 30, 2018 | -2.59 Mn |
| Jun 30, 2017 | -936,000.00 |
| Jun 30, 2017 | -936,000.00 |
| Dec 31, 2016 | 3.92 Mn |
| Dec 31, 2016 | 3.92 Mn |